Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Auxilium
>
Generic Androgel on the Way!!!! Testim Rules
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 3054657"]BRIEF-Solvay says subsidiary will not to file patent infringement suit against Perrigo Israel Pharmaceuticals </p><p>BRUSSELS, July 17 (Reuters) - Solvay SA (Brussels: SOLB.BR - news) : </p><p><br /></p><p>* Says its unimed pharmaceuticals LLC subsidiary will not to file a patent </p><p><br /></p><p>infringement suit against Perrigo Israel Pharmaceuticals, ltd </p><p><br /></p><p>* Says Unimed received a letter from Perrigo (NASDAQ: PRGO - news) advising Unimed that Perrigo had filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market and sell a generic version of AndroGel (testosterone gel) 1% CIII in the U.S. prior to the expiration of Unimed's patent </p><p><br /></p><p>* Says the receipt of these letters triggered a 45-day period during which time the company could have initiated patent infringement litigation and triggered a 30-month stay of FDA approval of Perrigo's ANDA </p><p><br /></p><p>* Says in its letter to the company, Perrigo asserted that it did not infringe the AndroGel patent because its proposed testosterone gel product contains a different formulation than the formulation protected by the AndroGel patent </p><p><br /></p><p>* Says the company does not waive its right to initiate patent infringement litigation at a later stage based on new or additional facts and circumstances </p><p><br /></p><p>((Brussels newsroom)[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 3054657"]BRIEF-Solvay says subsidiary will not to file patent infringement suit against Perrigo Israel Pharmaceuticals BRUSSELS, July 17 (Reuters) - Solvay SA (Brussels: SOLB.BR - news) : * Says its unimed pharmaceuticals LLC subsidiary will not to file a patent infringement suit against Perrigo Israel Pharmaceuticals, ltd * Says Unimed received a letter from Perrigo (NASDAQ: PRGO - news) advising Unimed that Perrigo had filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market and sell a generic version of AndroGel (testosterone gel) 1% CIII in the U.S. prior to the expiration of Unimed's patent * Says the receipt of these letters triggered a 45-day period during which time the company could have initiated patent infringement litigation and triggered a 30-month stay of FDA approval of Perrigo's ANDA * Says in its letter to the company, Perrigo asserted that it did not infringe the AndroGel patent because its proposed testosterone gel product contains a different formulation than the formulation protected by the AndroGel patent * Says the company does not waive its right to initiate patent infringement litigation at a later stage based on new or additional facts and circumstances ((Brussels newsroom)[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Auxilium
>
Generic Androgel on the Way!!!! Testim Rules
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Auxilium
>
Generic Androgel on the Way!!!! Testim Rules
>